Literature DB >> 16035560

CT in differential diagnosis of benign and malignant pleural disease.

U Yilmaz1, G Polat, N Sahin, O Soy, U Gülay.   

Abstract

BACKGROUND: CT plays a valuable role in assessment of patients with a wide variety of diseases of the pleura, and pulmonologists should be aware of the significance of different CT findings for the differential diagnosis of benign and malignant pleural diseases.
METHODS: 155 patients with pleural disease who had undergone CT scans of the lungs and thorax before treatment were enrolled. We retrospectively reviewed CT findings in 146 patients with proven pleural disease.
RESULTS: Fifty-nine of the cases were malignant, 87 of them had benign pleural diseases. CT findings that were helpful in distinguishing malignant from benign pleural disease were: 1) pleural nodularity; 2) rind; 3) mediastinal pleural involvement; and 4) pleural thickening greater than 1 cm. The sensitivities and specificities were 37%/97%, 22%/97%, 31%/85%, 35%/87%, respectively. CT findings differentiating malignant pleural mesothelioma from metastatic pleural disease were identified. Findings for malignant mesothelioma were as follows: 1) involvement of interlobar fissure (sensitivity 30%, specificity 92%), 2) pleural thickening greater than 1 cm (sensitivity 60%, specificity 77%). Whereas, findings for metastatic pleural disease were mediastinal/hilar lymph node enlargement and lung parenchymal involvement (P < .05).
CONCLUSION: CT is helpful in the differential diagnosis of pleural diseases, particularly in differentiating malignant from benign conditions and metastatic pleural disease from malignant mesothelioma.

Entities:  

Mesh:

Year:  2005        PMID: 16035560     DOI: 10.4081/monaldi.2005.653

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  10 in total

1.  Minimally invasive surgical treatment of malignant pleural effusions.

Authors:  Adrian Ciuche; Claudiu Nistor; Daniel Pantile; Teodor Prof Horvat
Journal:  Maedica (Buchar)       Date:  2011-10

2.  Diagnostic value of neurotrophin expression in malignant pleural effusions.

Authors:  Bernard C Duysinx; Astrid Paulus; Vincent Heinen; Delphine Nguyen; Monique Henket; Jean-Louis Corhay; Renaud Louis
Journal:  Exp Ther Med       Date:  2011-06-30       Impact factor: 2.447

3.  Massive localized malignant pleural mesothelioma (LMPM): manifestations on computed tomography in 6 cases.

Authors:  Weigen Yao; Hanqing Yang; Guolai Huang; Yang Yan; Honglin Wang; Dongfang Sun
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 4.  Video assisted thoracoscopic and open chest surgery in diagnosis and treatment of malignant pleural diseases.

Authors:  Periklis Perikleous; David A Waller
Journal:  J Vis Surg       Date:  2017-06-22

Review 5.  Diagnostic tools of pleural effusion.

Authors:  Moon Jun Na
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-05-29

Review 6.  Pleural effusion: diagnosis, treatment, and management.

Authors:  Vinaya S Karkhanis; Jyotsna M Joshi
Journal:  Open Access Emerg Med       Date:  2012-06-22

7.  [Clinical role of F-18 FDG PET/CT in differentiating malignant and benign pleural effusion in patients with lung cancer].

Authors:  Riqiang Liao; Xuening Yang; Siyun Wang; Qing Zhou; Qiang Nie; Wenzhao Zhong; Song Dong; Yilong Wu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-11

8.  Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura: A CT Challenge.

Authors:  Mehrdad Bakhshayesh Karam; Shirin Karimi; Leila Mosadegh; Samira Chaibakhsh
Journal:  Iran J Radiol       Date:  2016-01-14       Impact factor: 0.212

9.  Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT.

Authors:  Xirong Zhang; Haifeng Duan; Yong Yu; Chunling Ma; Zhanli Ren; Yuxin Lei; Taiping He; Ming Zhang
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

10.  Diffusion-weighted imaging diagnostic algorithm in patients with suspected pleural malignancy.

Authors:  Wenrui Jiang; Zhiping Han; Xing Tang; Hong Yin; Jian Zhang
Journal:  Eur Radiol       Date:  2021-05-28       Impact factor: 5.315

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.